Medication Overuse Headache
- Zaza KatsaravaAffiliated withDepartment of Neurology, University Hospital Essen, University of Essen
- , Hans-Christoph DienerAffiliated withDepartment of Neurology, University Hospital Essen, University of Essen
- , Volker LimmrothAffiliated withDepartment of Neurology, University Hospital Essen, University of Essen Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Medication overuse headache (MOH, formerly known as drug-induced headache) is a well known disorder following the frequent use of analgesics or any other antiheadache drug including serotonin 5-HT1B/D agonists (triptans).
Recent studies suggest clinical features of MOH depend on the substance class that has been overused. The delay between the frequent intake of any antiheadache drug and daily headache is shortest for triptans (mean 1.7 years), longer for ergot alkaloids (mean 2.7 years) and longest for analgesics (mean 4.9 years).
Treatment includes withdrawal followed by structured acute therapy and initiation of specific prophylactic treatment for the underlying primary headache. The relapse rate within 6 months after successful withdrawal is about 30% and increases steadily up to 50% after 5 years.
- Medication Overuse Headache
Volume 24, Issue 12 , pp 921-927
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors